CorMedix Appoints Mark A. Klausner, M.D. as Chief Medical Officer - Business Wire (press release) Print
Business Wire (press release)
Dr. Klausner has over 25 years of significant pharmaceutical experience spanning many functional and therapeutic areas, including extensive experience in the nephrology and cardiovascular therapeutic areas. Dr. Klausner joins CorMedix from Nephrogenex,

...